MedPath

A prospective randomized controlled study of "one-step" vs "two-step" self-expandable metallic stent placement for the management of distal biliary obstruction by unresectable pancreatic cancer.

Phase 3
Conditions
Distal biliary obstruction caused by unresectable pancreatic cancer
Registration Number
JPRN-UMIN000016010
Lead Sponsor
Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

1)Prognosis will be within 30 days 2)Having post gastrectomy with Billoth II or Roux-en-Y reconstruction 3)After percutaneous biliary drainage 4)Having history of SEMS placement for biliary obstruction 5)Having active infectious disease except acute cholangitis 6)Having severe acute cholangitis according to Tokyo Guidelines 7)Patients with the allergy to metal 8)Pregnant women or those suspected of pregnancy 9)Patients considered ineligible by attending physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to SEMS dysfunction
Secondary Outcome Measures
NameTimeMethod
Early(within 30 days after SEMS placement) and late complication, Overall survival, Bilirubin level decreasing rate, Total costs of SEMS-related interventions
© Copyright 2025. All Rights Reserved by MedPath